Skip to main content
Clinical Trials/NCT01862185
NCT01862185
Completed
Phase 3

Pengaruh Pemeriksaan Procalcitonin Semikuantitatif Terhadap Adekuasi Terapi Antibiotik Empirik Awal Dan Mortalitas Pada Pasien Sepsis

Indonesia University1 site in 1 country205 target enrollmentDecember 2012
ConditionsSepsis

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Sepsis
Sponsor
Indonesia University
Enrollment
205
Locations
1
Primary Endpoint
mortality rate
Status
Completed
Last Updated
12 years ago

Overview

Brief Summary

Sepsis is a serious clinical condition with a considerable morbidity and mortality. Procalcitonin (PCT) is a good biomarker for early diagnosis and infection monitoring. The present study aimed to investigate the effect of semi-quantitative PCT test to the empirical antibiotic initiation time, the appropriateness of empirical antibiotics and mortality in septic patients.

The hypothesis of the study are :

  • There is an effect on mortality between septic patients who do and do not do semi-quantitative PCT examination
  • There is an effect on empirical antibiotic initiation time between septic patients who do and do not do semi-quantitative PCT examination
  • There is an effect on appropriateness of empirical antibiotic between septic patients who do and do not do semi-quantitative PCT examination

Study design is randomized diagnostic trial which is also a pragmatic trial.

Registry
clinicaltrials.gov
Start Date
December 2012
End Date
April 2013
Last Updated
12 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Dana Dharaniyadewi

student

Indonesia University

Eligibility Criteria

Inclusion Criteria

  • aged more than 18 years old
  • have at least two concomitant systemic inflammatory response syndrome criteria
  • have focal infection
  • with or without sign of organ hypoperfusion or dysfunction

Exclusion Criteria

  • post operative patient
  • trauma patient
  • have obtained prior antibiotic
  • refused to participate

Outcomes

Primary Outcomes

mortality rate

Time Frame: 14 days

mortality in 14 days since the patients were included in this study

Secondary Outcomes

  • the timing of empirical antibiotic first dose(in 24 hours since the patient was diagnosis as sepsis)
  • the appropriateness of empirical antibiotic(in 24 hours since the patient was diagnosed as sepsis)

Study Sites (1)

Loading locations...

Similar Trials